Is Coronavirus the Spark That Telehealth Needs?

Posted by Victoria Summers on Fri, Mar 13, 2020

Earlier this year, experts agreed that telehealth was poised to become mainstream in 2020. Spurred by broad access through smartphones and supported by health plans across the U.S., telehealth finally has the financial reimbursement and regulatory guidelines to enable patients and physicians to connect online. But now, COVID-19 has come on the scene. With the outbreak of the coronavirus in China and its rapid spread around the world, private companies and governments have encouraged people to quarantine themselves if they believe that they may have the virus. But how do patients know if they have it? If they suspect that they do have it, how can they access care in a way that doesn’t expose others? And if patients have health questions unrelated to coronavirus, wouldn’t they prefer to stay away from clinics and hospitals to decrease their risk of exposure?


>
Read More

A New Delivery System for Next-Generation Cell and Gene Therapies

Posted by Maria Whitman on Thu, Apr 25, 2019

Kris Elverum of Turnstone Biologics co-wrote this blog post with Maria Whitman.

The evolution of medicines from small molecules to proteins has greatly advanced patient care, and up until now, our system of therapeutic delivery in the U.S. commercial system has been built with these therapeutics in mind. The next generation of cellular and gene therapies holds tremendous promise for patients, but only if the existing delivery system is revamped. There’s a real risk that most patients won’t benefit from these therapies as stakeholders struggle to find successful business models. In a recent article for Nature’s Gene Therapy, my industry colleague, Kris Elverum, and I take a critical look at the U.S. system and outline what needs to change to make approved cell and gene therapies accessible to patients.


>
Read More

A Majority of Patients Want AI to Improve Their Face Time With Physicians, ZS Research Finds

Posted by Paul Darling on Tue, Sep 25, 2018

Pratap Khedkar co-wrote this blog post, the second in a series on ZS’s 2018 AI in Healthcare study, with Paul Darling.

We trust artificial intelligence to navigate commuters around real-time traffic and pitch in when it’s time to cook dinner, and it’s even being called on to tackle the ever-looming laundry pile (for those who can afford the hefty price tag). AI also is well on its way to autonomously steering cars and landing airplanesalthough most consumers don’t feel comfortable completely foregoing human judgment when people’s lives are at stake.

We’ve found that that pretty much sums up how patients feel about AI’s potential role in healthcare delivery. They’re OK with AI taking on certain tasks, but they want the diagnoses and treatment decisions left in their physicians’ hands.


>
Read More

How Do Doctors Feel About Robots in the Exam Room?

Posted by Paul Darling on Wed, Aug 29, 2018

This blog post is the first in a series on ZS’s 2018 AI in Healthcare study.

Data-rich, technology-based solutions like artificial intelligence are lining up to transform many facets of healthcare, but before we start planning for the transformation that this technology can bring, we might want to do a reality check: Will AI truly be disruptive in an industry that has been slow to adopt new technologies, or will the change be incremental? And even if AI can improve care delivery, what do doctors—and patients—think about inviting AI into the exam room?


>
Read More